Immediate Impact

2 by Nobel laureates 18 from Science/Nature 52 hit
Sub-graph 1 of 24

Citing Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Hit
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Hit
1 intermediate paper

Works of Tsuyoshi Igarashi being referenced

A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment
2011

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tsuyoshi Igarashi 268 79 58 55 43 28 441
J. Greally 158 0.6× 54 0.7× 63 1.1× 39 0.7× 42 1.0× 39 395
Anna Maria Ongari 247 0.9× 76 1.0× 86 1.5× 31 0.6× 30 0.7× 28 470
Sangeeta Kumari 215 0.8× 81 1.0× 28 0.5× 43 0.8× 56 1.3× 29 417
Raquel Lorenzetti 184 0.7× 104 1.3× 35 0.6× 76 1.4× 22 0.5× 20 478
R Lomnitzer 196 0.7× 47 0.6× 54 0.9× 55 1.0× 21 0.5× 28 370
Donald S. Waldorf 159 0.6× 47 0.6× 81 1.4× 59 1.1× 81 1.9× 16 483
D. Piancatelli 273 1.0× 62 0.8× 72 1.2× 30 0.5× 26 0.6× 43 475
Joshua J. Michel 215 0.8× 116 1.5× 94 1.6× 30 0.5× 55 1.3× 19 482
Nico Andreas 234 0.9× 105 1.3× 43 0.7× 27 0.5× 36 0.8× 30 429
Agnieszka Gerkowicz 169 0.6× 86 1.1× 64 1.1× 44 0.8× 52 1.2× 32 451

All Works

Loading papers...

Rankless by CCL
2026